VIROBLOCK
Viroblock is a Swiss based company focused on developing a novel anti-viral technology that is both rapid acting and broad spectrum. Applied to non-woven fabric, the technology is particularly suited for air filtration products. In fact, previous work has shown Viroblock fabric to kill over 99% of H5N1 viruses when challenged in standardized aerobiology experiments.
VIROBLOCK
Social Links:
Industry:
Biotechnology Brand Marketing Fitness Health Care Marketing Medical Personal Health Technical Support Wellness
Founded:
2005-11-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.viroblock.com
Total Employee:
1+
Status:
Active
Contact:
41 22 884 83 46
Email Addresses:
[email protected]
Total Funding:
4.1 M CHF
Technology used in webpage:
Google Maps Swiss Server Location
Similar Organizations
Charlottesville Medical Research Center
Charlottesville Medical Research Center is focusing on World health and promote the well-being of our patients.
Inion
Inion is a medical devices company focused on the development and commercialization of innovative biodegradable applications.
Simon Patika
Simon Patika offers essential oils, ointment, night creams, minerals, cosmetics, medicines, ear drops, vitamins, and facial care products.
ULIV Holding
Biotech holding company specializes in developing and patenting innovative technologies aimed at improving overall health and real-time use.
Unibell
Unibell is a healthcare company that develops physiotherapy technology in combination with manual techniques and functional products.
YEP Lounge
YEP Lounge is a yoga studio that offers personal training, health insurance, wellness, fitness coaching, yoga training, and rehabilitation.
Youngevity
Youngevity is dedicated to delivering nutritional and healthy life style solutions and products.
Current Advisors List
Current Employees Featured
Founder
Investors List
StartAngels Network
StartAngels Network investment in Series C - Viroblock
Initiative Capital Romandie
Initiative Capital Romandie investment in Series B - Viroblock
Fongit Seed Invest
Fongit Seed Invest investment in Series B - Viroblock
BlueOcean Ventures
BlueOcean Ventures investment in Series B - Viroblock
Fongit Seed Invest
Fongit Seed Invest investment in Series A - Viroblock
Initiative Capital Romandie
Initiative Capital Romandie investment in Series A - Viroblock
Official Site Inspections
http://www.viroblock.com
- Host name: heiq1.rhone.ch
- IP address: 81.201.199.122
- Location: Visp Switzerland
- Latitude: 46.294
- Longitude: 7.8779
- Timezone: Europe/Zurich
- Postal: 3930
More informations about "Viroblock"
Viroblock - Crunchbase Company Profile & Funding
Feb 14, 2012 · Viroblock is a Swiss based company focused on developing a novel anti-viral technology that is both rapid acting and broad spectrum. Applied to non-woven fabric, the …See details»
Biotechnology startup | ViroBlock | COVID-19 | Jerusalem
ViroBlock is a biotech startup that uses advanced technologies to provide rapid solutions to viral diseases, such as COVID-19, Dengue, Zika, and more.See details»
A universal antiviral drug is being developed in Jerusalem
Jul 19, 2022 · ViroBlock, a Jerusalem-based startup, has developed a new drug platform for rapidly generating antiviral drugs that target proteins common to all Covid-19 variants and other viruses, including influenza, Zika, West Nile and …See details»
Viroblock Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Viroblock. Use the PitchBook Platform to explore the full profile.See details»
Viroblock - Funding, Financials, Valuation & Investors - Crunchbase
Viroblock is a Swiss company focused on developing a novel anti-viral technology suited for air filtration products.See details»
Viroblock, a Hebrew University Startup, Announces …
Jul 6, 2022 · According to a new study conducted by pharma research company Evotec, ViroBlock’s new technology platform demonstrated the potential to rapidly provide solutions for treating current and emerging viral threats, including …See details»
HU Startup Offers New Defense Against COVID …
July 6, 2022 – ViroBlock, a startup company founded by Hebrew University of Jerusalem (HU) researchers, developed a new drug platform for rapidly generating anti-viral drugs that target proteins common to all viruses.See details»
ViroBlock, a Hebrew University Startup, Announces Preliminary …
JERUSALEM, June 27, 2022 – ViroBlock, a startup company founded by the Hebrew University of Jerusalem (HU) researchers, has developed a new drug platform for rapidly generating anti …See details»
Viroblock - Contacts, Employees, Board Members, Advisors
Viroblock is a Swiss company focused on developing a novel anti-viral technology suited for air filtration products.See details»
Israeli startup develops drug platform to combat future COVID …
Jul 8, 2022 · Israeli startup ViroBlock announced on Wednesday the development of a new drug platform that could be used to treat future COVID-19 variants. Follow Israel Hayom on …See details»
Hebrew U Startup’s Viroblock Effective Against Covid Variants ...
Jul 6, 2022 · ViroBlock, a startup company founded by Hebrew University of Jerusalem researchers, has developed a new drug platform for rapidly generating anti-viral drugs that …See details»
HeiQ Viroblock | Antiviral and Antibacterial Technology
HeiQ Viroblock is designed to inhibit the growth and persistence of bacteria and enveloped viruses on textile surfaces. It’s a unique combination of our registered silver technology for …See details»
HeiQ Viroblock NPJ03 Antiviral Textile Technology Tested Effective ...
Mar 17, 2020 · Catalyzed to action by the global fight against Coronavirus, HeiQ launches HeiQ Viroblock NPJ03 (Viroblock), an antiviral and antimicrobial textile treatment which has proven …See details»
HeiQ Viroblock NPJ03 antiviral textile technology tested effective ...
IQ has forged a solid innovation track record helping brands improve textile products. Catalyzed to action by the global fight against Coronavirus, HeiQ launches HeiQ Viroblock NPJ03, an …See details»
HeiQ Viroblock Wins Prestigious And Coveted Swiss Technology …
Nov 20, 2020 · HeiQ Viroblock is one of the world’s most efficient and effective antiviral/antimicrobial technologies and has been applied by more than 150 brands worldwide …See details»
Swiss Technology Award 2020 for Viroblock
Nov 26, 2020 · It is among the first textile technologies in the world to be proven effective against Covid-19. HeiQ Viroblock consists of a combination of HeiQ’s patent-pending vesicle and …See details»
HeiQ : Viroblock tested successfully against virus that causes …
Aug 21, 2021 · Tests conducted by Swiss textile innovator HeiQ with the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia (Doherty Institute) showed that treated …See details»
HeiQ Viroblock NPJ03 antiviral textile technology tested effective ...
Mar 16, 2020 · HeiQ launches HeiQ Viroblock NPJ03, an antiviral and antimicrobial textile treatment that provides improved reduction of virus infectivity against coronavirus.See details»
Can Antimicrobial Clothing Fight COVID? - Gear Patrol
Apr 4, 2021 · Initially, these antimicrobial treatments — like Viroblock from Swiss chemical company HeiQ — were designed to help clothing prevent both odor and viral growth, but …See details»
Electrospun Nanofiber-Based Viroblock/ZnO/PAN Hybrid Antiviral …
Aug 27, 2021 · Designing novel antiviral personal protective equipment (PPE) is crucial for preventing viral infections such as COVID-19 in humans. Here, we fabricate an electrospun …See details»